22 results match your criteria: "Centre de Référence Maladies rénales rares Sorare[Affiliation]"
Arch Dis Child
October 2024
Paediatric Nephrology Department, Great Ormond Street Hospital for Children, London, UK.
Kidney Int Rep
July 2024
University of Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, Bordeaux, France.
Nephron
June 2024
Département de Néphrologie et Transplantation d'Organes, Centre de référence des maladies rénales rares (SORARE), French Intensive Care Renal Network (FIRN), University Hospital of Toulouse, Toulouse, France.
Background: Chemokines orchestrate immune cells activation and infiltration during acute kidney injury (AKI).
Objectives: We aim to test whether deletion of C-C chemokine ligand 7 (CCL7), a small chemokine related to CCL2 (MCP-1), may modulate AKI development and progression toward kidney fibrosis.
Method: Expression of CCL7 was quantified in murine cortical tubular (MCT) cells exposed to myoglobin or lipopolysaccharide or submitted to metabolic reprogramming.
Nephrol Dial Transplant
July 2024
Paediatric Nephrology Department, Great Ormond Street Hospital for Children, London, UK.
Nephrol Dial Transplant
March 2024
University Bordeaux, INSERM, Bordeaux Population Health, UMR1219, Bordeaux, France.
Background: The trajectories of haemoglobin in patients with chronic kidney disease (CKD) have been poorly described. In such patients, we aimed to identify typical haemoglobin trajectory profiles and estimate their risks of major adverse cardiovascular events (MACE).
Methods: We used 5-year longitudinal data from the CKD-REIN cohort patients with moderate to severe CKD enrolled from 40 nationally representative nephrology clinics in France.
Sci Rep
March 2023
INSERM, Bordeaux Population Health Research Center, UMR1219, Univ Bordeaux, Bordeaux, France.
We investigated the shape of the relationship between longitudinal uric acid (UA) and the hazard of kidney failure and death in chronic kidney disease (CKD) patients, and attempted to identify thresholds associated with increased hazards. We included CKD stage 3-5 patients from the CKD-REIN cohort with one serum UA measurement at cohort entry. We used cause-specific multivariate Cox models including a spline function of current values of UA (cUA), estimated from a separate linear mixed model.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
March 2023
Centre de Référence des Maladies Rares du Calcium et du Phosphate, filière OSCAR, France.
Introduction: Vitamin D-dependent rickets type 1A (VDDR1A) is a rare genetic disease associated with loss-of-function variations in the gene encoding the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1). Phenotype-genotype correlation is unclear. Long-term outcome data are lacking.
View Article and Find Full Text PDFJ Autoimmun
December 2022
Hôpital Cochin, Paris, France.
Background: Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are rare systemic necrotizing vasculitis. The national incidence and prevalence of GPA/MPA and patient mortality remain unknown in France. A real-life study using retrospective data from the French National Health Data System was set up to describe the epidemiology and demographic characteristics of hospitalized GPA and MPA patients, overall and by disease.
View Article and Find Full Text PDFKidney Int Rep
April 2022
Univ Bordeaux, Institut National de la Santé et de la Recherche Médicale, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France.
Introduction: Socioeconomic status (SES) is recognized as an important determinant of kidney health. We aimed to evaluate the association of social deprivation with different indicators at kidney replacement therapy (KRT) initiation in the French pediatric metropolitan population.
Methods: All patients with end-stage kidney disease (ESKD) who started KRT before 20 years old in France between 2002 and 2015 were included.
Pediatr Nephrol
April 2022
Service de Néphrologie Rhumatologie Et Dermatologie Pédiatriques, Centre de Référence Des Maladies Rénales Rares Néphrogones Filières Maladies Rares ORKID et ERK-Net, Hospices Civils de Lyon, Lyon, Bron, France.
Background: Lumasiran, a sub-cutaneous RNA-interference therapy, has been recently approved for primary hyperoxaluria type 1 (PH1), with doses and intervals according to body weight. Little is known as to its use in infants; the aim of this study was to describe treatment outcome in 3 infants who received lumasiran therapy before 2 years of age.
Case-diagnosis/treatment: Patient 1 was diagnosed antenatally and received lumasiran from day 9.
Clin Kidney J
December 2021
Assistance Publique des Hôpitaux de Paris, Hôpital Tenon, Service de Néphrologie et Dialyses, Paris, France.
Background: The spectrum of interferon-β (IFN-β)-associated nephropathy remains poorly described and the potential features of this uncommon association remain to be determined.
Methods: In this study we retrospectively analysed the clinical, laboratory, histological and therapeutic data of patients with biopsy-proven renal disease in a context of IFN-β treatment administered for at least 6 months.
Results: Eighteen patients (13 women, median age 48 years) with biopsy-proven renal disease occurring during IFN-β therapy were included.
Transplantation
February 2022
University of Bordeaux, Institute of Health and Medical Research, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France.
Background: Kidney transplantation (KT) is the optimal treatment for children with end-stage kidney disease. The aim of this study was to evaluate the impact of preemptive kidney transplantation (PKT) and of pretransplant dialysis duration on graft survival among French pediatric kidney transplant recipients.
Methods: We analyzed all first pediatric kidney-only transplantations performed in France between 1993 and 2012.
Pediatr Nephrol
January 2021
Pediatric Nephrology Unit, Centre de Référence Maladies Rénales Rares SoRare, Bordeaux University Hospital, Bordeaux, France.
Nephrol Dial Transplant
April 2021
INSERM, Bordeaux Population Health Research Center, University of Bordeaux, UMR1219, Bordeaux, France.
Background: Several models have been proposed to predict kidney graft failure in adult recipients but none in younger recipients. Our objective was to propose a dynamic prediction model for graft failure in young kidney transplant recipients.
Methods: We included 793 kidney transplant recipients waitlisted before the age of 18 years who received a first kidney transplantation before the age of 21 years in France in 2002-13 and survived >90 days with a functioning graft.
Pediatr Nephrol
June 2020
APHP, Néphrologie pédiatrique, Centre de Référence MARHEA, Hôpital Universitaire Necker-Enfants malades, 149 rue de Sèvres, 75015, Paris, France.
Background: Bi-allelic loss of function variations in genes encoding proteins of the renin-angiotensin system (AGT, ACE, REN, AGTR1) are associated with autosomal recessive renal tubular dysgenesis, a severe disease characterized by the absence of differentiated proximal tubules leading to fetal anuria and neonatal end-stage renal disease.
Case-diagnosis/treatment: We identified bi-allelic loss of function mutations in ACE, the gene encoding angiotensin-converting enzyme, in 3 unrelated cases displaying progressive chronic renal failure, whose DNAs had been sent for suspicion of juvenile hyperuricemic nephropathy, nephronophthisis, and cystic renal disease, respectively. In all cases, patients were affected with anemia whose severity was unexpected regarding the level of renal failure and with important polyuro-polydipsia.
Kidney Int
September 2019
University of Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health Research, Bordeaux, France; INSERM, Clinical Investigation Center-Clinical Epidemiology-CIC-1401, Bordeaux, France; Pediatric Nephrology Unit, Pellegrin-Enfants Hospital, Bordeaux University Hospital, Centre de Référence Maladies rénales rares Sorare, Bordeaux, France. Electronic address:
Socioeconomic status is an important determinant of health. Its impact on kidney transplantation outcome has been studied among adults but data in children are scarce, especially in Europe. Here, we investigate the association between the level of social deprivation (determined by the continuous score European Deprivation Index) and graft failure risk in pediatric kidney transplant recipients.
View Article and Find Full Text PDFRheumatology (Oxford)
December 2019
Département de Néphrologie et Transplantation d'Organes, et Centre de référence des Maladies Rénales Rares (SORARE), Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Arch Pediatr
November 2016
Centre de référence des maladies rénales rares MARHEA, unité de néphrologie pédiatrique, hôpital Robert-Debré, AP-HP, 75793 Paris cedex 19, France.
These guidelines are intended to assist physicians in the care of children with chronic kidney disease (CKD), defined in children as in adults, regardless of its cause. Often silent for a long time, CKD can evolve to chronic renal failure or end-stage renal disease. Its management aims at slowing disease progression and treating CKD complications as soon as they appear.
View Article and Find Full Text PDFPediatr Nephrol
October 2016
Service de Néphrologie Pédiatrique, Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Hôpital Necker-Enfants Malades, Assistance Publique- Hôpitaux de Paris, 149 rue de Sèvres, Paris Cedex 15, 75743, France.
Arch Pediatr
July 2015
Pédiatrie, néphrologie, médecine interne et hypertension pédiatrique, centre de référence du Sud-Ouest des maladies rénales rares (SORARE), hôpital des Enfants, CHU de Toulouse, 31300 Toulouse, France.
Observation of stunted growth in children usually leads the general practitioner to refer the patient to endocrinologists or gastroenterologists. In most cases, after a complementary check-up, the diagnosis is made and treatment is initiated. However, certain cases remain undiagnosed, particularly renal etiologies, such as proximal tubulopathy.
View Article and Find Full Text PDFNephrol Dial Transplant
September 2014
Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic inherited kidney disease, affecting an estimated 600 000 individuals in Europe. The disease is characterized by age-dependent development of a multiple cysts in the kidneys, ultimately leading to end-stage renal failure and the need of renal replacement therapy in the majority of patients, typically by the fifth or sixth decade of life. The variable disease course, even within the same family, remains largely unexplained.
View Article and Find Full Text PDFNephrol Ther
February 2012
Service de néphrologie et immunologie clinique, centre de référence des maladies rénales rares (SORARE), CHU de Toulouse, université de Toulouse III, hôpital Rangueil, avenue Jean-Poulhès, 31059 Toulouse cedex 9, France.
Acute pancreatitis and thrombotic microangiopathy is an established association: but which is the cause, which is the consequence? Thanks to two case reports and a literature review, we put to light an unequivocal link. Indeed, thrombotic microangiopathy may be responsible for ischemic pancreatitis. On the other hand, acute pancreatitis, whatever its cause, may trigger thrombotic microangiopathy.
View Article and Find Full Text PDF